Fatty acid binding proteins (FABPs) are cytosolic fatty acid chaperones whose biological role and mechanisms of action are not well understood. Here, we developed mice with targeted mutations in two related adipocyte FABPs, aP2 and mal1, to resolve their role in systemic lipid, glucose, and energy metabolism. Mice lacking aP2 and mal1 exhibited a striking phenotype with strong protection from diet-induced obesity, insulin resistance, type 2 diabetes, and fatty liver disease. These mice have altered cellular and systemic lipid transport and composition, leading to enhanced insulin receptor signaling, enhanced muscle AMP-activated kinase (AMP-K) activity, and dramatically reduced liver stearoyl-CoA desaturase-1 (SCD-1) activity underlying their phenotype. Taken together with the previously reported strong protection against atherosclerosis, these results demonstrate that adipocyte/macrophage FABPs have a robust impact on multiple components of metabolic syndrome, integrating metabolic and inflammatory responses in mice and constituting a powerful target for the treatment of these diseases.
Introduction
. Obesity is associated with abnormalities of these functional networks at many levels, including aberrant production Adipose tissue plays a critical role in energy homeostasis and an array of endocrine functions. Obesity, characterized by exand/or abnormal function of most of these mediators, leading to an array of associated pathologies (Friedman and Halaas, cess accumulation of adipose tissue, is detrimental to many systems and involved in the pathogenesis of multiple human 1998; Sethi and Hotamisligil, 1999; Shulman, 2000) . It is still not fully clear why these pathologies and complications cluster diseases (Saltiel, 2001; Spiegelman and Flier, 2001 ). These associated pathologies include insulin resistance, type 2 diabearound obesity to establish the phenotype known as metabolic syndrome. tes, dyslipidemia, cardiovascular disease, and fatty infiltration of the liver (Shulman, 2000; Tilg and Diehl, 2000) . Currently, Adipocytes are active sites of lipid metabolism involving storage, mobilization, and transport of lipids as well as utilizamore than 64.5% of the adult population in the United States are overweight (Skyler and Oddo, 2002) , and obesity and type tion of lipid-mediated signaling pathways. These cells contain high levels of a cytosolic fatty acid binding protein (FABP) 2 diabetes are the leading metabolic diseases worldwide (Flegal et al., 1998; Zimmet et al., 2001) . The incidence and the called aP2 (Bernlohr et al., 1999) . It is generally accepted that cytosolic FABPs in general, and aP2 in particular, facilitate the impact of this disease cluster, also referred to as metabolic syndrome, have risen to alarming proportions, and there is utilization of lipids in metabolic pathways in adipocytes and other cells. It is therefore likely that FABPs serve as a critical great need for therapeutic and preventive measures against these major health threats.
link between lipid metabolism, hormone action, and cellular functions in adipocytes and other cell types and thus contribThe systemic regulation of adiposity is controlled at many levels by mechanisms endogenous both to adipocytes and to ute to systemic energy homeostasis. However, the definitive biology and mechanisms of action of FABPs remain poorly paracrine and endocrine links with the central nervous system and other metabolically critical sites such as muscle and liver understood. Earlier studies have indicated a role for aP2 in glucose metabolism (Hotamisligil et al., 1996; Scheja et al., 1999 ; tissues. Lipids and their derivatives, as well as numerous cytokines and hormones, are important to the function of these net- . Mice deficient in aP2, despite gaining more weight, exhibit a modest increase in insulin sensitivity in the works in health and disease (Friedman and Halaas, 1998; Mat-context of obesity with no protection from fatty liver disease.
ence adiposity (see below). This weight difference was not obMore recently, a significant impact of this protein on the develserved in the aP2 −/− or mal1 −/− mice on regular diet ( Figure 1D ). opment of atherosclerosis through modification of macrophage To address the possibility of protection from excess adiposity inflammatory responses and cholesterol metabolism was obthoroughly, we placed aP2-mal1 −/− mice and wt littermates on served (Boord et al., 2002; Makowski et al., 2001) . A second a hig-fat (50% of total calories derived from fat) and high-calo-FABP isoform, mal1, is also expressed in adipocytes. Mice derie diet (5286 kcal/kg, Bioserve, NJ) along with a control group ficient in mal1 also exhibit a small increase in insulin sensitivity, in each genotype on regular rodent diet. On a high-fat diet, wt without changes in total body adiposity (Maeda et al., 2003) .
control mice developed marked obesity compared to mice fed Although mal1 is also expressed in macrophages in a similar a regular rodent diet ( Figure 1D ). However, in the aP2-mal1
−/− pattern with aP2, its role, if any, on atherosclerosis has not group, weight gain on the high-fat diet was significantly reyet been determined. Although normally found at low levels in duced (15%-16% between ages 8 and 20 weeks, Figure 1D ). adipose tissue, mal1 is strongly upregulated in animals lacking Again, this pattern differed from the single aP2 −/− and mal1 −/− aP2, thus preventing full understanding of FABP function and mice. Mice with mal1 mutation exhibited a smaller decrease in mechanism of action at this site and systemically (Hotamisligil total body weight, whereas, in aP2 −/− animal's body, weight et al., 1996; Makowski et al., 2001; Scheja et al., 1999) . To was higher than the wt controls on high-fat diet ( Figure 1D ). overcome this limitation and examine the impact of FABPs on adipocyte function and systemic metabolic homeostasis, we Adiposity in aP2-mal1-deficient mice developed mice lacking both aP2 and mal1 genes and examWe next assessed whether this reduction in total body weight ined the mechanisms underlying FABP function.
gain aP2-mal1 −/− is related to local and systemic alterations in adiposity by performing whole-body nuclear magnetic resoResults nance (NMR) spectroscopy ( Figure 1E ) and dual energy X-ray absorption (DEXA) analyses ( Figure 1F ). In imaging studies by Mice with combined aP2-mal1 deficiency NMR, all fat compartments were clearly reduced in the secTo address the impact of combined aP2-mal1 deficiency on tions prepared at the levels of neck, around kidneys, abdominal metabolic control, we have generated an intercross between region, and subcutaneous depots of the aP2-mal1 −/− mice C57BL/6J-aP2 −/− and C57BL/6J-mal1 −/− mice (Maeda et al., compared to the wt controls on both regular and high-fat-diet-2003). Although the estimated genetic distance between these fed animals ( Figure 1E ). In fact, the body composition of wt two genes was very close (0.1-0.15 cM), we were able to genmice on regular diet and aP2-mal1 −/− mice on high-fat diet aperate two recombination events between these loci out of 600 peared quite similar. To investigate the level of total systemic offspring in the F2 generation from a cross between aP2-reduction in adiposity, we next examined total body composimal1 −/+ (heterozygous mutant at both loci). The wild-type (wt) tion by DEXA and proton NMR (Sjogren et al., 2001 ). There was and mutant alleles segregated in the expected Mendelian rano significant difference in total body composition in aP2 −/− or tios. In double mutant animals, aP2 and mal1 expression were mal1 −/− mice compared to wt controls on either regular or highnot detectable in various adipose depots ( Figure 1A ). No comfat diet ( Figure 1F ). However, DEXA analyses demonstrated pensatory regulation in other major FABPs including liver, brain, significantly reduced total body adipose mass in aP2-mal1
intestine, or heart isoforms were observed in adipose tissue of mice both on regular and high-fat diet ( Figure 1F ). These results aP2-mal1 null mice (data not shown). There was also no aP2 were also confirmed with total body proton NMR analysis (Raand mal1 expression in macrophages of double mutant mice zani et al., 2002) , which exhibited 22% and 25.8% reduction in (data not shown). In immunoblotting experiments, no aP2 or total body fat in aP2-mal1 −/− mice compared to wt controls on mal1 protein was detectable in the adipose tissue of aP2-regular and high-fat diet, respectively. mal1 −/− mice ( Figure 1B ). We also examined the total cytosolic fatty acid binding capacity in adipose tissue of aP2-mal1
Energy metabolism in aP2-mal1 −/− mice and wt mice. As shown in Figure 1C , there was a significant
The two major components contributing to the systemic enreduction in fatty acid binding capacity in aP2-mal1 −/− adipose ergy balance and adiposity are energy intake and expenditure. tissue. This reduction was not evident in the single aP2-or
To identify potential contributors to body weight reduction, mal1-deficient mice, where there was only a small decrease in food intake and energy expenditure were examined in aP2-adipose tissue fatty acid binding capacity in aP2 −/− animals mal1 −/− and wt groups. Despite being leaner, the aP2-mal1
and no difference was evident in mal1 −/− mice compared to mice had no reduction in total daily food intake. In fact, these wild-type controls. There was no reduction in fatty acid binding animals consumed slightly more food, although this difference capacity in muscle of aP2-mal1-deficient mice, and the liver was statistically insignificant between genotypes on either regfatty acid binding activity was slightly increased as compared ular or high-fat diet (see Figure S1A in the Supplemental Data to wt (data not shown), suggesting that the loss of fatty acid available with this article online, and data not shown). When binding is specific to adipose tissue.
corrected for body weight, the increase in total food intake beThere was no gross apparent abnormality in reproduction, came more evident ( Figure S1A ). During the period of food ingrowth, and development of aP2-mal1 −/− mice under standard take measurements, body weight difference was again apparlaboratory conditions in either sex. Besides these initial obserent between genotypes ( Figure S1B ). There was also no vations, the rest of the detailed experimentation was performed difference in rectal temperature ( Figure S1C ) or fecal lipid in males. Despite normal axial growth, aP2-mal1 −/− mice exhibcontent ( Figure S1D ) between genotypes, ruling out fever or ited a reduction (5.2%) in total body weight compared to controls, suggesting that the absence of these FABPs might influintestinal malabsorption as underlying causes of reduced adi- mal1-deficient mice exhibited similar rates of physical activity in continuous 48 hr period measurements ( Figure S1E ). HowWe next determined whether differences in energy expenditure in aP2-mal1-deficient animals could account for the differever, there was a significant increase in the rates of carbon dioxide production ( Figure 1G ) and oxygen consumption (Figences in adiposity by performing indirect calorimetry studies and determination of physical activity. In these studies, aP2-ure 1H) in aP2-mal1 −/− mice compared to wt controls. Taken
together, these data demonstrate that the primary metabolic adiponectin (62%), leptin (52%), and TNFα (70%) mRNAs in aP2-mal1 −/− mice ( Figure 2D ) in the epididymal adipose depot mechanism underlying the reduction in adiposity in aP2-mal1 −/− mice is increased energy expenditure. compared to wt controls. Serum leptin level was also significantly (63.0%) reduced in aP2-mal1 −/− mice (13.04 ± 1.1 versus 4.8 ± 0.5 ng/ml in wt and aP2-mal1 −/− mice, respectively, Adipose tissue, lipid transport and distribution, and adipocytokines in aP2-mal1-deficient mice p < 0.005, Figure 2E ). Interestingly, the serum level of adiponectin was also decreased (15.1%) in the aP2-mal1 −/− animals There was no significant difference in the extent of adipocyte differentiation in aP2-mal1 −/− mouse embryonic fibroblasts (25.18 ± 1.0 versus 21.4 ± 1.1 µg/ml in wt and aP2-mal1
mice, respectively, p < 0.05, Figure 2F ). This is surprising, since compared to wt or heterozygous cells (data not shown). In light of these observations, we next considered the possibility that adiponectin levels typically correlate negatively with body weight (Arita et al., 1999) . Finally, there was no detectable cirthe combined lack of aP2 and mal1 alters the lipid profiles in tissues due to their differential affinity and transport properties.
culating TNFα in the aP2-mal1 −/− mice, whereas, in wt mice on high-fat diet, TNFα protein was detectable in serum (27.3 ± 7 To address this question, we isolated the fatty acid fraction from two different adipose tissue depots and quantified indivipg/ml). These results demonstrate that FABP deficiency results in alterations in lipids and adipocytokines, the two major dual fatty acids. We also performed parallel fatty acid profiling experiments in muscle and liver tissues and serum. These exclasses of metabolic regulators derived from adipose tissue. These changes also create a milieu that might have a strong periments revealed significant differences in fatty acid distribution between wt and aP2-mal1 −/− mice (Figures 2A and 2B ). impact on systemic insulin action, which is addressed below. Among saturated fatty acids, accumulation of shorter chain fatty acids such as myristic acid (14:0) was favored in aP2-Protection against insulin resistance in aP2-mal1 −/− mice Rising blood glucose and insulin levels in animals on high-fat mal1 −/− adipose and muscle tissues compared to stearic (18:0) or palmitic acid (16:0). Strikingly, liver exhibited the complete diet are an indicator of obesity-induced insulin resistance and development of type 2 diabetes. Measurement of blood gluopposite pattern of fatty acid distribution between aP2-mal1 −/− mice and wt controls. Among monounsaturated fatty acids, the cose levels demonstrated that obese wt mice developed hyperglycemia compared to lean controls (330 ± 7.2 versus ratios strongly favored myristoleic (14:1n-5c) and palmitoleic (16:1n-7c) acid in adipose and muscle tissues ( Figure 2B ). The 197 ± 6.1 mg/dl, p < 0.001). However, on the high-fat diet, aP2-mal1 −/− mice had significantly lower blood glucose concentralipid profiles were similar between the two adipose tissue depots studied. This distribution was not present in liver or setions compared to wt controls ( Figure 3A ). In fact, throughout the experiment, the blood glucose levels in aP2-mal1 −/− mice rum, where monounsaturated fatty acid ratio was extremely low compared to longer chain length fatty acids in aP2-mal1 −/− on high-fat diet were indistinguishable from those of lean wt animals on regular diet (196 ± 5.7 verus 197 ± 6.1 mg/dl). Blood mice. In a separate experiment, we also measured the adipose tissue lipid composition of all of the same fractions quantitaglucose levels on regular diet were also lower (163 ± 5.4 mg/dl), although to a lesser extent, in the aP2-mal1 −/− mice tively and obtained similar results in lipid distribution (data not shown).
compared to wt controls. Wt mice on high-fat diet developed hyperinsulinemia compared to those on regular diet (3.2 ± 0.7 Next, we examined whether the adipocyte FABPs regulate fatty acid transport properties, which might underlie the alterversus 0.65 ± 0.2 ng/ml p < 0.001). Blood insulin levels in aP2-mal1 −/− mice were significantly lower throughout the experiations observed in lipid composition in aP2-mal1 −/− adipose tissue. Typically, fatty acid uptake experiments are performed mental period compared to wt controls ( Figure 3B ) and were indistinguishable from those of wt lean mice (0.66 ± 0.1 versus by palmitic acid (16:0). When we also used this fatty acid in initial experiments, we have not observed any differences be-0.65 ± 0.2). Hence, these results indicate that the aP2-mal1-deficient animals might be protected from the development of tween genotypes ( Figure 2C ). As adipose tissue palmitic acid levels are also similar between genotypes, we next asked high-fat-diet-induced insulin resistance and diabetes.
To further investigate systemic insulin sensitivity, we perwhether fatty acid uptake differs between aP2-mal1-deficient and wt adipocytes for fatty acids with different chain lengths.
formed insulin (ITT) and glucose (GTT) tolerance tests in aP2-mal1 −/− mice and wt controls. Insulin resistance was evident in Interestingly, these experiments demonstrated that the uptake of stearic acid (18:0) was significantly reduced in aP2-mal1-wt mice upon high-fat diet. As shown in Figure 3C , the hypoglycemic response to insulin in aP2-mal1 −/− mice on high-fat deficient adipocytes. In contrast, fatty acid uptake was increased for lauric acid (12:0). These data provide a potential diet was indistinguishable from control animals on regular diet. GTT also revealed a higher degree of hyperglycemia in wt animechanism for the alterations in lipid composition in adipose tissue via chain length-selective regulation of fatty acid traffickmals throughout the experiment, compared to aP2-mal −/− mice on high-fat diet ( Figure 3D ). In this test, the responses recorded ing in adipocytes. In biochemical measurements of steadystate serum lipids, we observed a modest decrease in circuin aP2-mal1 −/− mice did not reach those of lean controls. While these responses were also improved in aP2 −/− and mal1 −/− lating triglycerides and a modest increase in free fatty acid concentrations (Table S1 ). These changes were observed in mice on high-fat diet, these changes were significantly smaller in magnitude ( Figures 3E and 3F ). The increase in insulin sensianimals on both regular and high-fat diets. There was no significant alteration in serum glycerol or total cholesterol levels betivity in ITT was most dramatic in aP2-mal1 −/− mice on highfat diet. The magnitude of increase in insulin responsiveness in tween genotypes.
We also investigated the expression patterns of several adithe aP2 −/− mice (38%) was smaller than that in aP2-mal1 −/− mice (55%) but greater than the mal1 −/− animals (15%) on the pose-derived hormones in adipose tissues from mice on highfat diet to determine the impact of these compositional changes high-fat diet ( Figure 3E ). Similar to the results of ITT, the magnitude of increase in glucose disposal relative to the wt controls on adipocytokines. There were reductions in the expression of in the aP2 −/− mice (28%) was smaller than the aP2-mal1
Muscle lipids, AMP-activated kinase activity, and insulin mice (45%) but greater than the mal1 −/− animals (9%) on highsensitivity in ap2-mal1-deficient mice fat diet ( Figure 3D ). These results demonstrate that the comThe reduction in body weight and adiposity in FABP-deficient bined deficiency of aP2 and mal1 resulted in a significant mice could have an influence on the insulin sensitivity. Howprotection from high-fat-diet-induced insulin resistance and ever, the impact of FABP deficiency on systemic insulin sensitivity is disproportionate to its effects on body weight and type 2 diabetes. , blue triangle dashed line, n = 14) mice on regular diet and wt (green square solid line, n = 12) and AM −/− (green square dashed line, n = 13) mice on high-fat diet. Glucose and insulin were measured after 6 hr daytime food withdrawal. Insulin (C) and glucose (D) tolerance tests performed on wt and AM −/− mice on regular and high-fat diet. Asterisk, p < 0.05. Insulin (E) and glucose (F) tolerance test in all mutants expressed as integrated area under the glucose disposal curves (AUC) for each genotype relative to wt controls on high-fat diet. Experiments are performed on 14-16 weeks of age at fasting state, n = 6-8 in each group. Error bars represent the SEM. hence should involve an independent direct impact on insulin muscle lipid content. In fact, total muscle triglyceride content was significantly lower ( Figure 4A ) in the aP2-mal1 −/− mice action. The dramatic increase in insulin sensitivity as well as changes in energy homeostasis, lipid profiles, and adipocytocompared to wt controls (0.044 ± 0.006 versus 0.066 ± 0.01 mg/g, respectively, p < 0.005). As stated before, there was also kines all point to the involvement of muscle tissue in the phenotype of FABP-deficient animals. A feasible mechanism in this a shift in the distribution of saturated fatty acids favoring in the aP2-mal1 −/− animals the shorter chain myristic (14:0) versus context is the alterations of lipid content and/or composition of the muscle (as shown earlier), which in turn activate insulin longer chain stearic (18:0) acid (Figure 2A ). We reasoned that this lipid environment would be favorable to insulin action and receptor signaling cascades and/or other pathways related to energy expenditure. To address this model, we first examined hence examined insulin sensitivity in isolated muscle strips and muscle tissues obtained from wt and aP2-mal1 −/− mice. In exenvironment observed in aP2-mal1 −/− muscle tissue. To investigate this question, we incubated cultured muscle cells with a periments with isolated primary muscle strips from wt and aP2-mal1 −/− mice, we observed a significant increase in insulinvariety of lipids and examined insulin-stimulated phosphorylation of Akt ( Figure 4C ). These experiments clearly showed that stimulated glucose transport capacity in aP2-mal1 −/− muscle cells ( Figure 4B ). This increase was evident in muscles obinsulin-stimulated phosphorylation of Akt was higher in the presence of shorter chain (12:0 and 14:0) fatty acids and tained from mice under both regular and high-fat diet ( Figure  4B ) but more striking in the latter, indicating essentially comstrongly inhibited in the presence of longer chain (16:0 and 18:0) fatty acids ( Figure 4C ). These findings demonstrate that plete rescue of glucose transport capacity in aP2-mal1 −/− cells despite exposure to high-fat diet. We next asked whether insulipid composition in the aP2-mal1 −/− muscle tissue was highly favorable for insulin action. We also studied insulin-stimulated lin action in muscle cells is altered as a function of the lipid ) and wildtype (wt) mice with high-fat-diet-induced obesity. These experiments reflect baseline activity at 16 wError bars represent theeeks of age. B) AMP-K-α1 activity in soleus muscle following 15 min saline (C) or leptin (L) treatment in AM −/− and wt mice with high-fat-diet-induced obesity (n = 5-6 for each condition). C) AMP-K-α2 activity in soleus muscle under the same conditions in (B). Asterisk, p < 0.05 *a = significantly different from baseline activity in wt controls; *b = significantly different from both baseline and stimulated activity in wt controls and also from baseline activity in AM −/− mice. D) The effects of fatty acid chain length on phosphorylation of AMP-K in cultured L6 myocytes. AMP-K phosphorylation is detected by a phosphospecific antibody. E) Fatty acid oxidation in soleus muscle isolated from AM −/− and wt mice. Error bars represent the SEM. Asterisk, p < 0.05. phosphorylation of Akt in the muscle tissue of aP2-mal1 −/− and kg i.v.) to age-and sex-matched wt and aP2-mal1 −/− mice on control mice on both regular and high-fat diet ( Figure 4D ). The high-fat diet. We then isolated the soleus muscle and deterphospho-Akt levels were similar between genotypes in mice on mined the ability of leptin to activate this kinase. Leptin adminregular diet except for a small increase in baseline Akt phosistration increased the AMP-K-α1 activity 50% over baseline in phorylation in aP2-mal1 −/− mice. There was, however, a signifiwt mice ( Figure 5B ). At the baseline, aP2-mal1 −/− mice exhibcant increase in phosphorylation of muscle Akt in aP2-mal1-ited significantly increased (2.1-fold) AMP-K-α1 activity comdeficient animals on high-fat diet both before and following pared to wt mice. In aP2-mal1 −/− animals, leptin further stiminsulin stimulation ( Figure 4D ). Similar results were also obulated the AMP-K-α1 activity (70% over baseline) in soleus tained in adipose tissue, where both insulin-stimulated glucose muscle, which was significantly higher (2-fold) than leptin-stimtransport and Akt activation were strikingly increased in aP2-ulated AMP-Kα1 activity in wt controls ( Figure 5B ). Leptin also mal1-deficient animals ( Figures 4E and 4F) . In adipose tissue, stimulated the AMP-Kα2 activity (4.1-fold over baseline) in wt the increase in baseline Akt phosphorylation in the lean aP2-animals ( Figure 5C ). As reported, this was more potent commal1 −/− animals appeared more evident. These data clearly depared to leptin's ability to stimulate the AMP-Kα1 isoform (Mimonstrate that, at the molecular level, aP2-mal1 deficiency renokoshi et al., 2002) . In aP2-mal1 −/− animals, baseline AMPsulted in striking protection from high-fat-induced inhibition of Kα2 activity in soleus muscle was significantly higher than wt insulin action in muscle and adipose tissues.
animals (3.9-fold) and already reached the levels observed in An important energy sensor in skeletal muscle is the AMPthe leptin-treated wt mice. Leptin treatment further stimulated activated kinase (AMP-K). Interestingly, this kinase is targeted AMP-Kα2 to even higher levels over the already increased by leptin, and its activation is a potential protective mechanism baseline activity in aP2-mal1-deficient mice ( Figure 5C ). We against lipid accumulation. The fatty acid oxidation induced in next asked whether the mechanism underlying the increase in muscle by leptin and adiponectin (Fruebis et al., 2001 ; Muoio AMP-K activity might be the alterations in lipid composition. To et al., 1997) and potentially the protection against obesity and approach this question, we exposed cultured muscle cells to diabetes might be related, at least in part, to their ability to fatty acids with various chain lengths and determined the induce AMP-activated protein kinase activity (Minokoshi et al., phosphorylation of AMP-K ( Figure 5D ). These experiments Winder and Hardie, 1999; Yamauchi et al., 2001) . We demonstrated that phosphorylation of AMP-K was significantly therefore determined whether AMP-K is differentially phoshigher in the presence of shorter chain (12:0 and 14:0) fatty phorylated in muscle tissue of aP2-mal1 −/− mice and wt conacids and inhibited in the presence of longer chain (16:0 and trols. Levels of total and phosphorylated AMP-K were mea-18:0) fatty acids ( Figure 5D ). Based on these observations, we sured in the soleus muscle by immunoblot analyses (Figure postulated that these alterations might lead to enhanced fatty 5A). Quantification of immunoblot analyses demonstrated a acid oxidation in muscle, which would be consistent with insignificant 2-fold increase in the amount of phosphorylated creased metabolic rate and reduced body weight. To address AMP-K in soleus muscle from obese aP2-mal1 −/− mice comthis, we determined fatty acid oxidation in soleus muscle strips pared to wt controls.
isolated from aP2-mal1 −/− mice and wt control animals. These To examine the level of activation of AMP-K in muscle in response to leptin, we administered recombinant leptin (1 mg/ experiments demonstrated significantly increased capability of aP2-mal1 −/− muscle for fatty acid oxidation ( Figure 5E ). Taken g, respectively, p < 0.05). This significant reduction in liver triglyceride content and hepatosteatosis was not evident in together, these data indicate that lipids of various lengths differentially impact muscle AMP-K activity, consistent with the aP2 −/− or mal1 −/− mice (data not shown). Interestingly, the portal free fatty acid levels were even higher in the aP2-mal1 −/− observed muscle tissue lipid composition, increased activation of AMP-K, and enhanced fatty acid oxidation in aP2-mal1-defimice compared to wt controls on high-fat diet ( Figure 6D ). This, along with the alteration in the liver lipid profile, suggests an cient animals. intracellular hepatic mechanism accounting for the lack of lipid accumulation in liver cells.
Protection against fatty liver disease in aP2-mal1-deficient mice
The lipid profile seen in liver with accumulation of longer chain fatty acids such as stearic acid is striking, since this The weight of the liver was reduced in the aP2-mal1 −/− animals on high-fat diet ( Figure 6A ). Consistent with the reduction in pattern was the opposite of lipid distribution detected in adipose and muscle tissues where there was accumulation in faliver weight, histological examination of liver sections revealed a dramatic reduction in fatty infiltration in aP2-mal1 −/− mice vor of shorter chain fatty acids. To test the potential impact of this lipid distribution on the development of hepatosteatosis, compared to the wt animals ( Figure 6B ). In fact, the histopathology of aP2-mal1 −/− livers on high-fat diet was indistinguishwe first tested the ability of lipids with various chain lengths to accumulate in cultured liver cells. These experiments demonable from livers of mice on regular diet.
Accumulation of lipids in the liver may involve several pathstrate that fatty acid chain length is inversely correlated with the ability to accumulate lipids in cultured liver cells where ways. To approach the mechanisms underlying the protection from fatty liver disease in the aP2-mal1 −/− mice, we first biolonger chain (16:0 and 18:0) fatty acids essentially lacked the ability to induce hepatosteatosis, therefore supporting the hychemically determined the liver triglyceride content. These experiments demonstrated significantly lower liver tissue tripothesis that lipid metabolism as well as composition might underlie the lack of fatty liver disease in aP2-mal1-deficient glyceride accumulation ( Figure 6C ) in the aP2-mal1 −/− mice compared to wt controls (1.28 ± 0.14 versus 1.89 ± 0.07 mg/ mice ( Figure 6E ). The lipid distribution pattern observed in the livers of aP2-mal1 −/− mice led us to postulate that likely loci reports indicating the inhibitory effects of long chain fatty acids that are affected might be fatty acid synthase (FAS) and/or steon insulin action (Chavez and Summers, 2003) . Consistent with aroyl-CoA desaturase-1 (SCD-1). Interestingly, SCD-1 expresthese findings, basal and insulin-stimulated phosphorylation of sion in liver cells was strongly suppressed by fatty acids but Akt in FABP-deficient mice is also significantly increased in adiwithout the same clear and dramatic effect of chain length pose and muscle tissues, accompanied by increased insulinseen in muscle ( Figure 6F ). Examination of SCD-1 expression stimulated glucose uptake at both sites. Second, we demonin the liver tissues of aP2-mal1 −/− mice and wt controls on strate that the lipid composition of muscle is altered to favor high-fat diet also demonstrated a striking defect in the expresshorter chain length fatty acids. This composition supports sion of SCD-1 in the liver tissue of aP2-mal1 −/− animals (Figure higher levels of AMP-K activity in cultured cells and, consistent 6F). This reduction in SCD-1 mRNA expression was associated with these observations, there is increased basal and stimwith a significant decrease in liver SCD activity ( Figure 6G ). In ulated muscle AMP-K activity, fatty acid oxidation, and contrast, there was no reduction in SCD activity in adipose increased energy expenditure in FABP-deficient mice. Conse-(3.17 ± 0.32 versus 2.89 ± 0.51 in wt and aP2-mal1 −/− mice, quently, the overall triglyceride content of the muscle, a wellrespectively) or muscle tissues (0.28 ± 0.04 versus 0.25 ± 0.04 established indicator of lipotoxicity, is also reduced in aP2-in wt and aP2-mal1 −/− mice, respectively). Interestingly, SCD-1 mal1 −/− animals, although the magnitude of this reduction is is recently reported to be the predominant peripheral target of moderate. Whether alterations in lipid uptake in muscle also leptin in liver. Upon treatment with leptin, or in ob/ob mice contribute to the muscle lipid composition and metabolism rewhere leptin expression is transgenically reconstituted, SCD-1 mains to be determined. Third, we demonstrated a significant expression in liver is strongly suppressed. However, the level reduction in liver SCD-1 expression and activity in FABP-defiof regulation seen in aP2-mal1 −/− mice is greater than what cient animals accompanied by increased longer chain fatty has been achieved through leptin administration or transgenic acids and striking resistance to fatty liver disease upon expoleptin production (Cohen et al., 2002; Soukas et al., 2000) , sugsure to a high-fat diet. These changes occur despite higher gesting that its regulation may not be entirely related to leptin systemic and portal fatty acid input. We also demonstrated the action at this site.
differential impact of exposure to fatty acids of different chain Finally, we examined the expression patterns of other molelength on SCD-1 expression and the capacity to induce lipid cules that are critical in liver lipid metabolism, including the accumulation in liver cells. The reduction in SCD-1 expression SREBP family of transcription factors, acetyl-CoA carboxylase seen in FABP-deficient animals is highly relevant to their liver 1 (ACC-1), and fatty acid synthase (FAS), to be able to conphenotype, since genetic SCD-1 deficiency also results in struct a better mechanistic model (Table S2) . Among all of the strong protection from hepatosteatosis and an overall phenogenes examined, the most dramatic regulation was for SCD-1 type reminiscent of FABP-deficient model presented here (Co-(96% reduction in aP2-mal1 −/− mice). Interestingly, these exhen et al. , 2002) . Finally, we demonstrate that aP2-mal1 defiperiments also demonstrated reduction (70%) in liver SREBP1c ciency results in decreased SREBP1c expression in liver and a expression in aP2-mal1-deficient mice. Consistent with this, consequent reduction in the transcriptional target genes for we also detected moderate decreases in the expression of a this key transcription factor for liver lipid metabolism. This is a number of additional SREBP1 target genes critical in fatty acid likely response triggered by the elevated fatty acid levels delivmetabolism, including ACC-1, FAS, ELOVL6, SPOT14, HMGered through the portal system to liver. Interestingly, however, CoA reductase, and HMG-CoA synthase (Table S2 ). In con-SREBP2 expression is not altered by FABP deficiency. It has trast, no change was evident in the expression levels of been shown that SREBP2 expression is upregulated in the liver SREBP2, DGAT1, or mGPAT.
tissue of SREBP1c-deficient mice, leading to increased liver cholesterol synthesis (Shimano et al., 1997 ). In the current Discussion model, despite decreased SREBP1c expression, there is no compensatory upregulation of SREBP2 in the liver tissue of Fatty acids have long been seen as critical components of the aP2-mal1-deficient mice, which also provides further protecpathogenesis of obesity and its associated disorders. However, tion from hepatosteatosis with decreased HMG-CoA reductase the mechanisms by which these or other lipids mediate these and HMG-CoA synthase expression. abnormalities remain unclear. Our findings in this study demonIt is of note that both muscle AMP-K and liver SCD-1 have strate that FABPs are critical in the interface between cellular recently been established as major targets for peripheral leptin lipid trafficking and homeostasis and the peripheral signaling action. In this study, we also show data supporting enhanced pathways that are central to obesity and its associated patholactivation of AMP-Kα1 and α2 isoforms in the muscle tissue ogies. The deletion of two FABPs, aP2 and mal1, in mice of aP2-mal1 −/− animals. Furthermore, AMP-K is also targeted causes significant changes in lipid and hormone profiles and by adiponectin, and adiponectin-stimulated AMP-Kα1 activity leads to significant protection against obesity, insulin resisin muscle is also enhanced in aP2-mal1-deficient animals (data tance, type 2 diabetes, and fatty liver disease. not shown). These observations raise the interesting possibility In FABP-deficient animals, there is an increase in the ratio of that at least part of the impact of FABPs on systemic metaboshorter chain (C14) to longer chain (C18) fatty acids in adipose lism is either dependent on leptin and/or adiponectin activity and muscle tissues. This pattern is reflected in circulating lipids or mimicking peripheral actions of these molecules. Since there but reversed in liver. We have presented several intermediary were no recognizable changes in food intake but a significant mechanisms in this lipid environment that underlie the phenoincrease in energy expenditure in aP2-mal1 −/− mice, we sugtype of the mice. First, we demonstrated the differential impact gest that the primary site of action in these animals is at the of exposure to fatty acids of different chain length on muscle insulin receptor signaling. These results are in line with previous periphery, whether or not it is dependent on leptin activity. Ad- ditional studies in leptin-or adiponectin-deficient models could (Boord et al., 2002 (Boord et al., , 2004 Makowski et al., 2001) . These results address these questions further.
clearly demonstrate that FABPs integrate metabolic and inWe demonstrate significant alterations in fatty acid transport, flammatory responses in adipocytes and macrophages and availability, and composition upon loss of intracellular FABPs.
that they are central to the development of key pathologies These activities have not been associated with cytosolic associated with metabolic syndrome. Taken together with the FABPs in previous studies. Interestingly, since systemic free impact of FABPs on atherosclerosis, results presented here ilfatty acid levels are not decreased in FABP deficiency, our data lustrate that blocking the activity of FABPs would constitute supports the concept that transport and availability of fatty novel and powerful therapeutic opportunities, which could be acids to the target tissues and the intracellular responses elicexploited through straightforward biochemical assays based ited by these lipids are more critical in determining the metaon ligand replacement, in obesity and associated disorders bolic outcomes than the absolute values present in circulation.
such as insulin resistance, type 2 diabetes, hepatosteatosis, Regarding the latter, an interesting possibility remains that and cardiovascular disease. FABPs might also alter stress and inflammatory responses, in- , and C57BL/6J-wt control mice on a high-fat diet
These results also illustrate that the aP2-mal1 −/− mice differ (Diet F3282, Bioserve, NJ) in which 50% of the calories are provided in the from the individual deficiency of aP2 and mal1 in several reform of fat. This model of dietary obesity and insulin resistance is milder than that of the genetic models and considered similar to the extent of spects (Table 1) . First, whereas aP2-mal1 −/− mice are protected disease in the majority of humans (Uysal et al., 1997) . Mice were placed on from obesity, aP2-or mal1-deficient mice show no difference this diet at 4 weeks of age and followed until week 20. A control group on in systemic adiposity (Maeda et al., 2003) , and aP2 −/− mice regular rodent diet was also included to determine the efficiency of the diet actually gain more weight upon induction of dietary or genetic and comparisons with the obese group.
obesity (Hotamisligil et al., 1996; Scheja et al., 1999; . In addition, no difference in metabolic rates is obImaging studies T 2 -weighted MR images were collected on a 4.7 T/40 cm horizontal bore served in aP2-or mal1-deficient animals, whereas aP2-mal1-Varian MR imager. Mice were positioned in a 3.8 cm imaging volume coil.
deficient animals exhibit increased O 2 consumption and CO 2
The temperature inside the probe is maintained at 32°C. T 2 -weighted improduction. Second, the magnitude of the increase in insulin aging experiments were performed using a spin echo multislice sequence sensitivity observed in aP2-mal1 deficiency significantly ex- ciency models has substantial physiological significance.
injected into peritoneal cavity at the dose of 0.5 U/kg and 1.0 mL/kg (1 M Finally, in our earlier studies, we have also observed that solution), respectively. Blood was collected via tail vein at different time FABP-deficient mice are dramatically protected against atheropoints, and glucose levels were measured by the use of a glucometer (Precision). Serum insulin, leptin, and adiponectin levels were measured sclerosis through the action of these FABPs in macrophages with RIAs for rat insulin and mouse leptin and adiponectin (Linco Research). acid-free BSA (Sigma) and 200 µl of 10% trichloroacetic acid were added and then mixed. After centrifugation (5000 × g, 10 min), radioactive counts Serum lipid concentrations were determined by established assays as previously described (Maeda et al., 2003; .
in the supernatant were measured by a scintillation counter. The enzyme activity was expressed as nmol min −1 mg −1 protein. FABP proteins were detected by immunoblotting with antisera raised against full-length human Liver and muscle triglycerides, fatty acid analysis, and treatments mal1 and aP2 in adipose tissue extracts prepared as described (Scheja et Soleus muscle was carefully dissected from mice to limit fat contamination. al., 1999) . Phosphorylation of the α subunit of AMP-K in soleus lysates Triglyceride in soleus muscle or liver tissue was determined using a comwas determined with gradient SDS-PAGE gels using an antibody against mercial kit (Determiner TG, Kyoma Medex, Japan). Total lipids were exphosphopeptides based on the amino acid sequence surrounding Thr172 tracted from serum by the method of Dole and Meinertz (1960) . Free fatty of either α1 and α2 isoforms of the catalytic subunit of AMP-K (Cell Signalacids were separated from esterified fatty acids by thin layer chromatograing). Protein levels of AMP-K were determined using an antibody for both phy using silica gel and a mixture of petroleum ether:diethyl ether: acetic α1 and α2 subunits of AMP-K (Cell Signaling). AKT and phospho-AKT antiacid (80:20:1) as the stationary and mobile phases, respectively. Fatty acids bodies were purchased from Cell Signaling. RNA extraction and gene exwere methylated by incubation (50°C, 1 hr) with methanol/acetyl chloride pression studies are detailed in the Supplemental Data. (20:1), evaporated, redissolved in isooctane, and separated by gas chromatography. Individual fatty acids were identified by comparison to purified standards. C2C12 myoblasts were cultured in DMEM containing 10% fetal Statistical analysis All numerical data were expressed as mean, and error bars represent the bovine serum, and differentiation was induced by DMEM supplemented with 2% horse serum. Cells were treated with fatty acids, as described SEM. Two-tailed, two-sample, unequal variance Student's t tests were used to assess statistical significance where p < 0.05 was the accepted level of (Chavez and Summers, 2003) . On day 4 of differentiation, cells were incubated with indicated fatty acid (0.75 mM in DMEM with 1% FBS, 2% BSA) statistical significance. for 20 hr. Cells were changed into serum-free medium containing the same fatty acid 4 hr prior to experiment and then treated with or without insulin Supplemental data (100 nM, 10 min). L6 cells were cultured and differentiated as described Supplemental Data include one figure, two tables, Supplemental Experi- (Tong et al., 2001 ) and treated with fatty acids on day 7. Fao cells mainmental Procedures, and Supplemental References and can be found with tained in DMEM with 10% FBS were washed with PBS twice and treated this article online at http://www.cellmetabolism.org/cgi/content/full/1/2/107/ with free fatty acids in DMEM with 2% BSA for 24 hr. DC1/.
Fatty acid binding and uptake assay FA binding activity was determined as described (Glatz and Veerkamp, Acknowledgments 1983) using Lipidex. The detailed protocol is provided in the Supplemental Data. For uptake experiments, epididymal fat pads from five to six 12-weekThis work was supported in part by grants from NIH (DK64360 to G.S.H. old mice were collected and digested with collagenase. The floating adipoand DK56116 and DK57521 to B.B.K.) and Pew Foundation and American cytes were washed three times with Krebs-Ringer phosphate isolation Diabetes Association (G.S.H.). K.M. is recipient of a fellowship from Manpei buffer containing 20 mM HEPES (pH 7.4), 2.5% BSA, 200 µM adenosine, Suzuki Diabetes Foundation, H.C. is recipient of a mentor-based fellowship and 5 mM glucose. Cell suspension (200 µl) was incubated with 3 H-labeled from American Diabetes Association, M.F. is recipient of a fellowship from lauric, myristic, palmitic, or stearic acid at a final concentration of 100 µM the Japan Society for the Promotion of Science, and Q.C. is supported by at 37°C for 30 min. Following the incubation, the uptake was terminated by NIH training grant T32-DK07703. We thank Laurie Goodyear's lab for help adding ice-cold stop solution containing 0.1% BSA and 200 µM phloretin in setting up the uptake and oxidation assays in muscle and Franks Sacks in isolation buffer. The cell suspension was then transferred onto a Whatand Hannia Campos for help in fatty acid composition analysis. H.M., B.K., man glass filter and washed three times with ice-cold PBS. The radioactivity and R.A.P. are employed by a for profit company developing drugs for diaof the filters was measured by a liquid scintillation counter.
betes.
Glucose uptake, AMP-K enzyme activity, and fatty acid oxidation Glucose uptake assays in muscle strips and primary adipocytes were performed as described (Abel et al., 2001; Bruning et al., 1998) . For AMP-K Received: July 23, 2004 enzyme assay, mice were housed in individual cages and, 5 days before
